The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiomic profiling of LRRC15 in triple negative breast cancer (TNBC).
 
Dan Morgenstern Kaplan
No Relationships to Disclose
 
Sachin Kumar Deshmukh
Employment - Caris Life Sciences
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
Gilberto Lopes
Stock and Other Ownership Interests - Biomab; CDR-Life; Lucence Diagnostics; Morphometrix; Xilis
Honoraria - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Dr. Reddy's Laboratories; Janssen; Merck; Rigel
Consulting or Advisory Role - AstraZeneca; Coherus Biosciences; Dr. Reddy's Laboratories; Mirati Therapeutics; Pfizer; Regeneron
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); BMS (Inst); E.R. Squibb Sons, LLC; EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Lucence; Lucence; Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst); Xilis
Travel, Accommodations, Expenses - AstraZeneca; BeiGene; Boehringer Ingelheim; Celgene; Coherus Biosciences; Dr. Reddy's Laboratories; E.R. Squibb Sons, LLC; Ipsen; Janssen; Merck; Pfizer; Pharmacyclics; Seagen; Seagen
 
Frances Valdes
Honoraria - Adverum (I); Allergan (I); BVI (I); EyePoint Pharmaceuticals (I); Genentech (I); NGM Biopharmaceuticals (I); Novartis (I); Valeant Pharmaceuticals International (I)
Consulting or Advisory Role - Adverum (I); AGTC (I); Apellis Pharmaceuticals (I)
Research Funding - Atreca (Inst); Hibercell (Inst); Merck (Inst); Molecular Templates (Inst); Orinove (Inst)
Expert Testimony - Mylan (I)
 
Traci King
No Relationships to Disclose
 
Sophia George
Research Funding - GlaxoSmithKline; Pfizer
 
Judith Hurley
No Relationships to Disclose
 
Ana Salazar
No Relationships to Disclose
 
Santiago Sucre
No Relationships to Disclose
 
Dario Trapani
No Relationships to Disclose
 
Pooja Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I); AstraZeneca (Inst); Epic Sciences; Epic Sciences; GE Healthcare; Menarini Group; OncLive/MJH Life Sciences
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); AstraZeneca (Inst); BMS (I); Breathe BioMedical; Puma Biotechnology
Speakers' Bureau - AstraZeneca (Inst); GE hea; Menarini
Research Funding - Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); biovica (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Seagan (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
Priya Jayachandran
No Relationships to Disclose
 
Maryam Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Menarini; Novartis; Osmol Therapeutics; Pfizer
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
George Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Priscila Barreto Coelho
No Relationships to Disclose